Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bellus Health
Biotech
After $2B acquisition, GSK sends some Bellus workers packing
After GSK’s $2 billion buyout of Canada-based Bellus Health, an undisclosed number of the biotech’s team members are out of a job.
Gabrielle Masson
Mar 22, 2024 11:08am
After Merck's cough drama, GSK knew what to do with Bellus asset
Nov 30, 2023 8:00am
GSK inks $2B Bellus buyout to challenge Merck for cough market
Apr 18, 2023 4:45am
Merck responds to FDA letter for chronic cough med gefapixant
Aug 5, 2022 10:21am
Merck's chronic cough med gets a nay from FDA
Jan 24, 2022 10:50am
Bellus offers a scrap of analysis for chronic cough candidate
Sep 13, 2021 10:40am